Therapeutics: Claudin 5 (CLDN5); occludin (OCLN); β amyloid (Aβ)

Neurology

INDICATION: Alzheimer's disease (AD)

In vitro and mouse studies suggest inhibiting CLDN5 and

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE